Evaluating Humoral Immune Response to mRNA COVID-19 Vaccines in Siponimod-treated Patients with Advancing Forms of Relapsing Multiple Sclerosis: A COVID-19 Vaccine Sub-study of Phase 3b EXCHANGE Trial
Multiple Sclerosis Journal
; 28(1_SUPPL):80-81, 2022.
Article
in English
| Web of Science | ID: covidwho-1865844
Search on Google
Collection:
Databases of international organizations
Database:
Web of Science
Type of study:
Experimental Studies
/
Randomized controlled trials
Topics:
Vaccines
Language:
English
Journal:
Multiple Sclerosis Journal
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS